Caris Life Sciences (CAI) — insider trading
Health Care
Caris Life Sciences (CAI) has 12 reported SEC Form 4 insider transactions in our data, including 2 open-market purchases among the most recent 12 (latest 2026-05-29).
Recent Form 4 transactions
| Date | Insider | Role | Type | Shares | Price | Value | Filing |
|---|---|---|---|---|---|---|---|
| 2026-05-29 | Knowles Jonathan Kenneth Charles | Director | Grant / award / vesting | 1,600 | $15.62 | $25.0K | Form 4 |
| 2026-05-29 | POSTE GEORGE | Director | Grant / award / vesting | 1,600 | $15.62 | $25.0K | Form 4 |
| 2026-05-15 | HALBERT JON | Director | Open-market purchase | 68,000 | $14.56 | $990.1K | Form 4 |
| 2026-05-15 | HALBERT DAVID D | Director, Officer (See Remarks), 10% owner | Shares withheld for taxes / exercise cost | 40,712 | $15.25 | $620.9K | Form 4 |
| 2026-05-15 | Brille Brian J | Director, Officer (See Remarks) | Shares withheld for taxes / exercise cost | 13,987 | $15.25 | $213.3K | Form 4 |
| 2026-05-15 | Spetzler David Baxley | Officer (President) | Shares withheld for taxes / exercise cost | 13,856 | $15.25 | $211.3K | Form 4 |
| 2026-05-15 | Power Luke Thomas | Officer (See Remarks) | Shares withheld for taxes / exercise cost | 9,771 | $15.25 | $149.0K | Form 4 |
| 2026-05-15 | Denton John Russel | Officer (See Remarks) | Shares withheld for taxes / exercise cost | 6,047 | $15.25 | $92.2K | Form 4 |
| 2026-05-11 | Vacirca Jeff L | Director | Open-market purchase | 31,050 | $16.15 | $501.4K | Form 4 |
| 2026-03-06 | Spetzler David Baxley | Officer (President) | Grant / award / vesting | 83,162 | $0.00 | $0 | Form 4 |
| 2026-03-06 | Denton John Russel | Officer (See Remarks) | Grant / award / vesting | 63,971 | $0.00 | $0 | Form 4 |
| 2026-03-06 | Power Luke Thomas | Officer (See Remarks) | Grant / award / vesting | 63,971 | $0.00 | $0 | Form 4 |
Ask the chat about CAI's insider activity →
Transaction types are the SEC Form 4 codes: open-market purchases (P) and sales (S) are the only rows that reflect open-market conviction. Awards/vesting (A), option exercises (M/X/C), shares withheld for taxes (F) and gifts (G) are compensation or mechanical, not buying or selling on the open market. Sales may be planned and non-discretionary (e.g. a Rule 10b5-1 plan); open-market buying is not a recommendation to buy. Informational only — not financial advice.
Source: SEC EDGAR Form 3/4/5. See the full company profile: Caris Life Sciences (CAI).
Last updated 2026-05-29 (most recent filing date).
Informational only — NOT financial advice. Insider filings are sourced from SEC EDGAR and shown with their reported dates.